Barry Ticho

Barry Ticho is a seasoned Life Sciences veteran, whose extensive career spans academic medicine and biotechnology innovation. He is the Founder of Verve Therapeutics and Chief Medical Officer at Stoke Therapeutics, a biotech company addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines.

With an MD-PhD from the University of Chicago and extensive experience across academia and industry, Barry brings over two decades of expertise in clinical development. He has held roles as Head of Development at Moderna, Head of External R&D Innovation at Pfizer, and VP of Clinical Development at Biogen, where he's been instrumental in advancing numerous therapeutic programs across multiple disease areas. Barry provides a unique perspective that's invaluable for aspiring leaders in the field.